BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18976543)

  • 1. Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907.
    Singh RK; Dai Y; Staudinger JL; Muma NA
    Int J Neuropsychopharmacol; 2009 Jun; 12(5):651-65. PubMed ID: 18976543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the JAK-STAT pathway by olanzapine is necessary for desensitization of serotonin2A receptor-stimulated phospholipase C signaling in rat frontal cortex but not serotonin2A receptor-stimulated hormone release.
    Singh RK; Jia C; Garcia F; Carrasco GA; Battaglia G; Muma NA
    J Psychopharmacol; 2010 Jul; 24(7):1079-88. PubMed ID: 19304867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine increases RGS7 protein expression via stimulation of the Janus tyrosine kinase-signal transducer and activator of transcription signaling cascade.
    Singh RK; Shi J; Zemaitaitis BW; Muma NA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):133-40. PubMed ID: 17392403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex.
    Muma NA; Singh RK; Vercillo MS; D'Souza DN; Zemaitaitis B; Garcia F; Damjanoska KJ; Zhang Y; Battaglia G; Van de Kar LD
    Neuropharmacology; 2007 Sep; 53(4):552-62. PubMed ID: 17675105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 attenuates serotonin 2a receptor signaling by activating the JAK-STAT pathway.
    Donegan JJ; Patton MS; Chavera TS; Berg KA; Morilak DA; Girotti M
    Mol Pharmacol; 2015; 87(3):492-500. PubMed ID: 25549668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-2A homodimers are needed for signalling via both phospholipase A
    Iglesias A; Cimadevila M; Cadavid MI; Loza MI; Brea J
    Eur J Pharmacol; 2017 Apr; 800():63-69. PubMed ID: 28216047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-HT 2A serotonin receptor enhances cell viability, affects cell cycle progression and activates MEK-ERK1/2 and JAK2-STAT3 signalling pathways in human choriocarcinoma cell lines.
    Oufkir T; Arseneault M; Sanderson JT; Vaillancourt C
    Placenta; 2010 May; 31(5):439-47. PubMed ID: 20338635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of JAK2 by serotonin 5-HT (2A) receptor activates both STAT3 and ERK1/2 pathways and increases growth of JEG-3 human placental choriocarcinoma cell.
    Oufkir T; Vaillancourt C
    Placenta; 2011 Dec; 32(12):1033-40. PubMed ID: 21993263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
    Kehne JH; Ketteler HJ; McCloskey TC; Sullivan CK; Dudley MW; Schmidt CJ
    Neuropsychopharmacology; 1996 Aug; 15(2):116-24. PubMed ID: 8840347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.
    Kehne JH; Baron BM; Carr AA; Chaney SF; Elands J; Feldman DJ; Frank RA; van Giersbergen PL; McCloskey TC; Johnson MP; McCarty DR; Poirot M; Senyah Y; Siegel BW; Widmaier C
    J Pharmacol Exp Ther; 1996 May; 277(2):968-81. PubMed ID: 8627580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.
    Chernet E; Martin LJ; Li D; Need AB; Barth VN; Rash KS; Phebus LA
    Life Sci; 2005 Dec; 78(4):340-6. PubMed ID: 16139310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
    Xu J; Jian B; Chu R; Lu Z; Li Q; Dunlop J; Rosenzweig-Lipson S; McGonigle P; Levy RJ; Liang B
    Am J Pathol; 2002 Dec; 161(6):2209-18. PubMed ID: 12466135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.
    Olijslagers JE; Perlstein B; Werkman TR; McCreary AC; Siarey R; Kruse CG; Wadman WJ
    Eur J Pharmacol; 2005 Sep; 520(1-3):77-85. PubMed ID: 16154561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein.
    Shi J; Damjanoska KJ; Zemaitaitis B; Garcia F; Carrasco G; Sullivan NR; She Y; Young KH; Battaglia G; Van De kar LD; Howland DS; Muma NA
    Neuropharmacology; 2006 Sep; 51(3):524-35. PubMed ID: 16769091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2A serotonin receptor agonist DOI alleviates cytotoxicity in neuroblastoma cells: role of the ERK pathway.
    Marinova Z; Walitza S; Grünblatt E
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():64-72. PubMed ID: 23380172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway.
    Wang L; Kurosaki T; Corey SJ
    Oncogene; 2007 May; 26(20):2851-9. PubMed ID: 17146444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
    Benaliouad F; Kapur S; Rompré PP
    Neuropsychopharmacology; 2007 Mar; 32(3):551-61. PubMed ID: 16794561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of 5-HT7 Serotonin Receptors by the Atypical Antipsychotics Clozapine and Olanzapine. Role of Motifs in the C-Terminal Domain and Interaction with GASP-1.
    Manfra O; Van Craenenbroeck K; Skieterska K; Frimurer T; Schwartz TW; Levy FO; Andressen KW
    ACS Chem Neurosci; 2015 Jul; 6(7):1206-18. PubMed ID: 25706089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.